(photo: )

Heat Biologics, University of Miami collaborate on Zika vaccine

Immuno-oncology company Heat Biologics has entered into an agreement with the University of Miami to license and develop a portfolio of patents aimed at the Zika virus and other infectious diseases.



  •  (photo: )

    New report renews efforts to tackle scourge of counterfeit medicines

    A new report from the European Observatory on Infringements of Intellectual Property Rights assessing the economic impact of counterfeiting and piracy in the pharmaceutical sector has been welcomed by the European Federation of Pharmaceutical Industries and Associations (EFPIA).



  •  (photo: )

    Horizon seals deal for Raptor Pharmaceutical

    Horizon Pharma, a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, has completed its acquisition of Raptor Pharmaceutical.



 (photo: )

FDA approves Merck’s Zinplava to reduce CDI recurrence

Merck, known as MSD outside the United States and Canada, today announced that the US Food and Drug Administration (FDA) has approved Zinplava (bezlotoxumab) Injection 25 mg/mL.

 (photo: )

NIBSC, NIFDS MoU promotes biological standardisation

The UK’s National Institute of Biological Standards and Control (NIBSC) and the National Institute of Food and Drug Safety Evaluation (NIFDS) from the Republic of Korea have signed a memorandum of understanding (MoU).


 (photo: )

Yorkshire pharma firm targets overseas medicine exports

A new medicines and pharmaceuticals wholesaler and distributor has been launched to solve difficulties faced by millions of people in Iraq in obtaining modern medicines to treat many illnesses effectively.

 (photo: )

Yorkshire medical diagnostic company inks global distribution deal

Yorkshire-based medical diagnostic company Abingdon Health as entered into a multi-year, global distribution agreement with electrophoresis specialist Sebia.


 (photo: )

Martindale’s clobazam oral suspension approved in 7 EU countries

Epaclob, the clobazam oral suspension product from UK pharmaceutical company Martindale Pharma has gained regulatory approval in seven European countries.

 (photo: )

GSK submits shingles vaccine for US regulatory approval

GlaxoSmithKline has submitted a Biologics License Application for its candidate shingles vaccine, ShingrixTM, to the United States Food and Drug Administration, seeking approval for the prevention of shingles in people aged 50 years or over.